Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTEMPO: Duvelisib Combinations in Untreated FL
NCT02391545Phase 2Terminated
- Sponsor
- Secura Bio
- Start
- Dec 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of duvelisib in follicular lymphoma (FL), sponsored by Secura Bio. Started Dec 2014; status: terminated.
02
Drugs
duvelisib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02391545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02391545.